Hospice’s purpose, at least one of them, is to ease a dying patient’s pain at the end of life and improve the quality of that life. But what’s to be done when a dementia patient in her waning days can’t…

Continue reading

As of July 1, the FDA had 4,036 generic drug applications awaiting approval. The FDA has approved more generics the past few years, but a flood of new applications has steadily added to the demand.

Continue reading

Teen pregnancy is way down. And a study suggests that the reason is increased, and increasingly effective, use of contraceptives.

Continue reading

Following weeks of criticism, Mylan said Monday it will offer a generic version of its life-saving allergy treatment, the EpiPen. But what does this development mean for consumers and the marketplace?…

Continue reading

An increasing number of elderly patients nationwide are on multiple medications to treat chronic diseases, raising their chances of dangerous drug interactions and serious side effects. Often the drugs are prescribed by different specialists who don’t communicate with each other.

Continue reading

A surprising ingredient — infant gas relief drops — may be contributing to the contamination of medical scopes nationwide.

Continue reading

Full-blown puberty is irreversible, but for transgender children, it’s no longer inevitable, thanks to puberty blockers.

Continue reading

Kids from less affluent homes, even when they have health insurance, are less likely to get vision screenings for irreversible eye conditions, a new study found.

Continue reading

Some hospitals and medical providers think that the hot-new technology in town — ride-hailing services such as Uber and Lyft — can address a problem for patients.

Continue reading

Buried in the fine print of many marketplace health plan documents is language that allows them to refuse to cover a range of services, many of which disproportionately affect women, a recent study found. It’s unclear the extent to which…

Continue reading